TrialHuman vaccines & immunotherapeutics2015

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.

Markus Knuf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.